High Prevalence of Abscesses and Cellulitis Among Community-Recruited Injection Drug Users in San Francisco

Published in: Clinical Infectious Diseases, v. 30, no. 3, Mar. 2000, p. 579-581

Posted on RAND.org on January 01, 2000

by Ingrid A. Binswanger, Alex H. Kral, Ricky N. Bluthenthal, Daniel J. Rybold, Brian R. Edlin

Read More

Access further information on this document at www.journals.uchicago.edu

This article was published outside of RAND. The full text of the article can be found at the link above.

The prevalence of and risk factors for abscesses and cellulitis were investigated among a community sample of injection drug users (IDUs). Participants were interviewed, and those with symptoms were examined. Of 169 IDUS, 54 (32%) had abscesses (n = 35), cellulitis (n = 5), or both (n = 14); 27% had lanced their own abscesses; and 16% had self-treated with antibiotics they purchased on the street. IDUs who skin-popped (injected subcutaneously or intramuscularly) were more likely to have an abscess or cellulitis than those who had injected only intravenously (odds ratio, 4.9; 95% confidence interval, 2.2-1 1). The likelihood of abscesses and cellulitis increased with frequency of skin-popping and decreased with increasing duration of injection drug use. Abscesses are extremely prevalent among IDUs in San Francisco. Skin-popping is a major risk factor, and self-treatment is common.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.